J.B. Hunt just delivered one of the clearest single-stock signals that the freight recovery is real. The reason is not simply that earnings beat consensus; it is that the beat came with volume growth, margin leverage, and management commentary pointing to intermodal conversion as truck capacity tightens. Q2 revenue rose 19% to $3.50 billion, EPS climbed 45% to $1.91, and the strongest business inside the company got stronger. That is exactly what a cycle turn looks like when the leader is pulling ahead.
The most important proof point sits inside intermodal, not in the headline EPS number. JBI revenue rose 22% to $1.75 billion, operating income jumped 58% to $150.9 million, and volume increased 10% year over year. Even better, this was not just price doing the work: management tied the demand strength to customers shifting freight because intermodal offers a better value proposition when fuel is higher and truck capacity is tighter. When a network business grows loads and expands profit much faster than revenue, that is operating leverage, not accounting noise.
The recovery also looks broader than one segment carrying the whole story. ICS revenue rose 49% and swung back to a $1.7 million operating profit from a loss a year ago, which matters because it suggests the freight backdrop is improving beyond rail conversion alone. Add in an earnings beat rate of 7 out of the last 8 quarters, including an 11.7% surprise this quarter, and the pattern starts to look durable rather than accidental. The market is reading it that way for a reason: JBHT has outperformed Industrials by 38.3 percentage points year to date, and its Momentum component in the TickerSpark Score is a perfect 100.
The chart is confirming the fundamentals instead of fighting them. JBHT is trading at $297.44, essentially right under its 52-week high of $299.76, while sitting well above its 50-day moving average of $272.79 and its 200-day moving average of $217.23. That is not a stock struggling to prove a thesis; that is a stock being accumulated into strength. Public analyst commentary after the quarter also leaned the same way, with consensus still at Buy and one firm lifting its target to $297 on intermodal growth and conversion momentum.
The cleanest knock on the bull case is valuation. At 42.39 times trailing earnings and 17.87 times EV/EBITDA, JBHT is not cheap for a transporter, especially against peers like EXPD at 29.29 times earnings. The company’s trailing growth screen also looks mixed, with reported year-over-year revenue down 0.7% and the Growth component of the TickerSpark Score at just 40. If this were a low-quality rally, that combination would be enough to walk away.
It also is fair to say the quarter was not perfect across every business line. Truckload revenue rose 35%, yet that segment still posted a $1.3 million operating loss, and Final Mile revenue fell 6% with operating income down 30%. That is the real caution flag. Still, the bullish read wins because the market is paying for the segment that is driving the cycle turn, and that segment just posted 10% volume growth with 58% operating-income growth. When the best business is accelerating that hard, the weaker pieces matter less unless they start dragging on consolidated results in a meaningful way.
What matters now is whether JBHT can hold this breakout as the next freight data points come in. We would respect the move as long as the stock stays above its 50-day trend and management keeps showing that intermodal volume growth is translating into margin expansion, not just revenue pass-through. A stock making new highs with accumulation, a 100 Momentum score, and a fresh earnings catalyst is not where we would get cute on the short side.
The trigger that would change our mind is straightforward: if truck capacity loosens enough to kill the conversion story, or if the next quarter shows intermodal volume stalling while the weaker segments keep leaking profit, the premium multiple stops making sense fast. Until that happens, JBHT looks like a leader in a turning freight tape, and we think the market is right to treat it that way.